olmesartan medoxomil has been researched along with Myocarditis in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kishimoto, C; Nimata, M; Shioji, K; Yuan, Z | 1 |
| Hasegawa, K; Kishimoto, C; Kita, T; Nimata, M; Okabe, TA; Shioji, K; Yuan, Z | 1 |
2 other study(ies) available for olmesartan medoxomil and Myocarditis
| Article | Year |
|---|---|
Beneficial effects of olmesartan, a novel angiotensin II receptor type 1 antagonist, upon acute autoimmune myocarditis.
Topics: Administration, Oral; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Autoimmune Diseases; Dose-Response Relationship, Drug; Female; Imidazoles; Interleukin-1; Male; Myocarditis; Myocardium; Myosins; Olmesartan Medoxomil; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Swine; Tetrazoles | 2004 |
Olmesartan, a novel AT1 antagonist, suppresses cytotoxic myocardial injury in autoimmune heart failure.
Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Autoimmune Diseases; Blood Pressure; Body Weight; Cardiomyopathies; Disease Models, Animal; Heart Failure; Heart Rate; Imidazoles; Interleukin-1; Lymphocytes; Myocarditis; Myocardium; Myosins; Olmesartan Medoxomil; Organ Size; Rats; Rats, Inbred Lew; Receptor, Angiotensin, Type 1; Tetrazoles | 2005 |